McCoy et al. 1. McCoy A.B. Cox Z.L. Neal E.B. et al. Real-time pharmacy surveillance and clinical decision support to reduce adverse drug events in acute kidney injury: a randomized, controlled trial. Appl Clin Inform. 2012; 3: 221-238 Crossref PubMed Scopus (29) Google Scholar concluded that real-time “pharmacy surveillance had no incremental benefit” compared with preexisting clinical decision support (CDS) systems (e.g., computer alerts) in detecting and preventing medication errors. Nearly 400 acute kidney injury patients were studied in a 3-month randomized clinical trial. Adult patients were enrolled who experienced a ±0.5 mg/dL change in serum creatinine over 48 hours. They had an active order for one or more nephrotoxic or renally cleared medications. In addition to CDS alerts and usual care pharmacy services (e.g., rounding with medical and surgical teams), the intervention included real-time monitoring of drug prescribing and kidney function trends by pharmacists using a Web-based surveillance tool. Blinded judges determined that potential or actual adverse drug events (ADEs) occurred for 104 (8.0%) usual care and 99 (7.1%) intervention group patients (P = 0.4). Time until providers modified or discontinued targeted nephrotoxic or renally cleared medications did not differ between usual care and intervention patients (33.4 vs. 30.3 hours, P = 0.3).
Read full abstract